Anaferon child drops 25ml

Mechanism of action

Immunomodulators. Antiviral agents.

In the course of preclinical and clinical studies, the effectiveness of the drug against influenza viruses, parainfluenza, herpes simplex viruses of types 1 and 2 (labial herpes, genital herpes), other herpes viruses (chickenpox, infectious mononucleosis), enterovirus, tick-borne encephalitis, rotavirus virus, was proved., calicivirus, adenovirus, respiratory syncytial (MS virus).

The drug reduces the concentration of the virus in the affected tissues, affects the system of endogenous interferons and associated cytokines, induces the formation of endogenous "early" interferons (IFN a / β) and gamma Interferon (IFN γ). Stimulates the humoral and cellular immune response. It increases the production of antibodies (including secretory IgA), activates the functions of T-effectors, T-helpers (Tx), normalizes their ratio. Increases the functional reserve of Tx and other cells involved in the immune response. It is an inducer of the mixed Tx1 and Tx2-immune response: it increases the production of cytokines Tx1 (IFN γ, IL-2) and Tx2 (IL-4, 10), restores (modulates) the balance of Tx1 / Tx2. Increases the functional activity of phagocytes and natural killer cells (EC cells).It has antimutagenic properties.

Indications

Treatment of acute respiratory infections of the upper respiratory tract in children aged 1 month to 3 years inclusive.

Contraindications

Increased individual sensitivity to the components of the drug, children up to 1 month.

Use during pregnancy and lactation

The safety of using Anaferona Infant in pregnant women and during lactation has not been studied.

Composition

The composition of 1 ml of drops for oral administration

Active substances:

Antibodies to human gamma interferon affinity purified - 0.006 g *.
* are introduced as a mixture of three active aqueous dilutions of the substance, diluted 100 ^ 12, 100 ^ 30, 100 ^ 50 times, respectively.

Excipients:

maltitol - 0.06 g, glycerol - 0.03 g, potassium sorbate - 0.00165 g, anhydrous citric acid - 0.0002 g, purified water - up to 1 ml.

Dosage and administration

10 drops per reception (drops are metered into a spoon). On the first day of treatment: the first 2 hours, 10 drops every 30 minutes, then, in the remaining time, another 3 times at regular intervals. From the 2nd to the 5th day: 10 drops 3 times a day.
The drug is taken outside the meal. On the first day of treatment, the first five doses of the drug should be carried out between feedings or 15 minutes before feeding a child or taking a liquid.

Side effects

When used according to the indicated indications and in the indicated dosages, no side effects were revealed.
Possible reactions increased individual sensitivity to the components of the drug.

Overdosage

Cases of overdose so far not identified.

Storage conditions

At temperatures not above 25 ° C.
Keep out of the reach of children.